2023-12-27 10:55:57
United States finds nearly half of new COVID cases infected with JN.1 subtype
The US Centers for Disease Control and Prevention (CDC) reports that the novel coronavirus (COVID-19) subtype JN.1 (JN.1) is spreading rapidly in the United States and currently accounts for nearly half of COVID-19 patients. According to Xinhua News Agency, JN.1 is classified as a subtype of the COVID virus that spreads the fastest and is one of the main epidemic strains in the country.
The CDC’s report indicates that JN.1 now occupies a higher proportion than 44% of COVID-19 patients, which is a significant increase from 21.4% in the previous period. The agency also notes that the JN.1 subtype is most prevalent in the northeastern United States, particularly in New Jersey and New York, where it accounts for nearly 57% of COVID-19 cases.
JN.1 was first detected in the United States in September 2023 and is closely related to the BA.2.86 (BA.2.86) strain, which the CDC has been monitoring since August. The subtype is known to spread more rapidly than other COVID subtypes and may be more adept at evading the immune system.
The rapid spread of JN.1 raises concerns about the potential impact on public health and the strain it could place on the healthcare system. The CDC continues to monitor the situation closely and advises the public to remain vigilant in following recommended safety measures to protect against the spread of COVID-19.
As the United States grapples with the surge in JN.1 cases, health officials and researchers are working to better understand the characteristics of this subtype and develop strategies to effectively combat its spread.
The emergence of JN.1 serves as a reminder of the ongoing threat posed by COVID-19 and underscores the importance of robust public health measures and vaccination efforts to mitigate the impact of the virus. The CDC urges individuals to stay informed, get vaccinated, and take precautions to protect themselves and others from COVID-19.
The CDC’s findings highlight the urgency of addressing the JN.1 subtype and the need for collective action to combat the ongoing COVID-19 pandemic. Read more news for the latest developments on the situation.]
#United #States #Covid #patients #infected #JN.1 #subtype #Bangkok #Insight